Indegene Limited — Updates, 28-04-2025: Press Release

Indegene reported a 4.9% QoQ revenue growth, reaching ₹7,556 million in Q4FY25, with a PAT of ₹1,176 million, reflecting a 7.2% QoQ increase. Full-year revenue surged 9.6% YoY to ₹28,393 million, while PAT increased by 20.8% YoY to ₹4,067 million. The company launched its first dividend at 100% for FY25 and enhanced its capabilities with the launch of the Cortex GenAI platform. Recognized as a front-runner in GenAI for Life Sciences, Indegene continues to build on recent deal wins, positioning for further growth.